Finding similar frequencies of positive acetylcholine receptor antibodies in patients with ocular and generalized myasthenia gravis (MG), a Danish research team posits that ocular disease is most ...

Patient 1, a 67-year-old female, presented with a complex, progressive course of myasthenia gravis, initially diagnosed 5 years ago. Her initial symptomatology included right eyelid ptosis, which ...

Patients <18 years old were considered as ‘paediatric’. Patients were considered as having OMG if they sustained solely ocular signs after at least 2 years of follow-up. The severity of MG was ...

Overlap syndromes involving myasthenia gravis, myositis and myocarditis are recognised adverse effects of immune checkpoint inhibitors (ICI). We report a similar syndrome of myasthenia gravis and ...

Myasthenia gravis (MG) does not have stages but classes ... The individual may have weakness in the ocular muscles of any severity. Class 5 This class is the most severe, affecting the muscles ...

Excitingly, in myasthenia [gravis], we have entered the advanced therapy era with the approval of the complement inhibitors starting in 2017, and now, more recently, the FcRn [neonatal Fc receptor ...

Background: The ability to distinguish between a normal thymus, thymic hyperplasia, and thymoma should aid in clinical management and decision making for patients with myasthenia gravis (MG). We ...

imm.ox.ac.uk Background: Myasthenia gravis is a potentially serious but treatable muscle disease caused by autoantibodies directed at the acetylcholine receptor (AChR) on the postsynaptic membrane of ...

There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied ... There are two types of autoimmune MG: ocular and ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.